CTSB and early-onset autosomal dominant Alzheimer disease: Multiple studies on Alzheimer’s disease pathology demonstrated anti-amyloidogenic properties of CTSB or CTSL [81, 86, 87] via direct [81, 88] or indirect enhancement of its enzymatic activity [87, 89, 90].